A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical Study
Condition:   Knee Osteoarthritis Interventions:   Drug: glucosamine sulphate 1500mg and meloxicam 15mg;   Drug: Glucosamine sulfate 1500mg and chondroitin sulfate 1200mg;   Drug: Placebos Sponsor:   Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2019 Category: Research Source Type: clinical trials

Maximizing Outcomes in Treating Acute Migraine
Condition:   Migraine Interventions:   Drug: AXS-07 (MoSEIC meloxicam and rizatriptan);   Drug: Meloxicam;   Drug: Rizatriptan;   Drug: Placebo Sponsor:   Axsome Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2019 Category: Research Source Type: clinical trials